Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity
about
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosisNeuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Alpha-Synuclein as a Biomarker for Parkinson's Disease.Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spacesDiscovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease.Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in SynucleinopathiesPosttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease.An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression.Combining clinical and biofluid markers for early Parkinson's disease detection.A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease.
P2860
Q28082380-1F5D8519-81AD-46D0-9419-5E7710C31663Q30394681-11B39F83-A5D6-4086-907F-1D2F19795CCBQ36109452-F7E38695-F818-4E01-9573-5C252A59B6C5Q38669105-7BA5AF4A-3D1B-442B-B2D2-7150A26B0C41Q38759482-B98CA849-564B-4241-8D44-5527A24E7F81Q38825497-9D4B5599-49F7-42CC-9E80-FFDCFD184186Q38834595-E927FA15-2DAC-4066-AE53-92EBC95BD839Q39366291-8EB36B8D-E0E7-418C-8ADA-E8F85622857AQ39466212-23D1D19F-E7CB-4FFD-9A4D-DD70A9E7E926Q39691980-7BEC0190-4166-4B2C-BF64-D378B7631145Q41653656-4E20E052-230F-4B5D-839B-E0880D1AA0C9Q42653035-3B5D2A59-282A-4F13-94B8-502B62E1F75DQ47941297-0EDDBA7F-5567-4C75-BFB3-E0375B7F85E3Q49202410-0469EF24-B545-4325-9FFE-0E77DCBD1E3AQ49613405-60E4DA81-2435-4EB6-8191-BC058C27F73AQ52609727-A3103F4F-A5A9-417B-9411-C74902257298
P2860
Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phosphorylated α-synuclein in ...... on depends on disease severity
@ast
Phosphorylated α-synuclein in ...... on depends on disease severity
@en
Phosphorylated α-synuclein in ...... on depends on disease severity
@nl
type
label
Phosphorylated α-synuclein in ...... on depends on disease severity
@ast
Phosphorylated α-synuclein in ...... on depends on disease severity
@en
Phosphorylated α-synuclein in ...... on depends on disease severity
@nl
prefLabel
Phosphorylated α-synuclein in ...... on depends on disease severity
@ast
Phosphorylated α-synuclein in ...... on depends on disease severity
@en
Phosphorylated α-synuclein in ...... on depends on disease severity
@nl
P2093
P2860
P50
P921
P1476
Phosphorylated α-synuclein in ...... on depends on disease severity
@en
P2093
Carmen Ginghina
Cyrus P Zabetian
Jan O Aasly
Jing Zhang
Kazuko Hasegawa
Kevin C Cain
Peggy Auinger
Ryan J Uitti
Teruo Yokoyama
Tessandra Stewart
P2860
P2888
P356
10.1186/S40478-015-0185-3
P577
2015-01-31T00:00:00Z
P5875
P6179
1040170544